Elizabeth Halton
- Oncology top 5%
- Genetics top 10%
- Biomedical Engineering
- Immunology
- Molecular Biology
- Co-authors
- Renier J. BrentjensIsabelle RivièreMichel SadelainXiuyan WangClaudia DiamonteJae H. ParkBrigitte SénéchalTerence J. Purdon
- Topics
- CAR-T cell therapy research (28 papers)Acute Lymphoblastic Leukemia research (6 papers)Biosimilars and Bioanalytical Methods (6 papers)
- Cited by
- OncologyGeneticsImmunology
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Elizabeth Halton
29 papers receiving 596 citations
Peers
Comparison fields: 5 of 33
- Oncology 555
- Genetics 187
- Biomedical Engineering 141
- Immunology 129
- Molecular Biology 117
Countries citing papers authored by Elizabeth Halton
This map shows the geographic impact of Elizabeth Halton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Halton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Halton more than expected).
Fields of papers citing papers by Elizabeth Halton
This network shows the impact of papers produced by Elizabeth Halton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Halton. The network helps show where Elizabeth Halton may publish in the future.
Co-authorship network of co-authors of Elizabeth Halton
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Halton. A scholar is included among the top collaborators of Elizabeth Halton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Halton. Elizabeth Halton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 24 | |
| 3 | 47 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 44 | |
| 7 | 69 | |
| 8 | 9 | |
| 9 | 8 | |
| 10 | 9 | |
| 11 | 2 | |
| 12 | 3 | |
| 13 | 60 | |
| 14 | 37 | |
| 15 | 1 | |
| 16 | 6 | |
| 17 | 13 | |
| 18 | 20 | |
| 19 | 1 | |
| 20 | 17 |
About Elizabeth Halton
Elizabeth Halton is a scholar working on Oncology, Genetics and Immunology, having authored 29 papers that have together received 604 indexed citations. Recurring topics across this work include CAR-T cell therapy research (28 papers), Acute Lymphoblastic Leukemia research (6 papers) and Biosimilars and Bioanalytical Methods (6 papers). The work is most often cited by research in Oncology (555 citations), Genetics (187 citations) and Immunology (129 citations). Elizabeth Halton has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Renier J. Brentjens, Isabelle Rivière, Michel Sadelain, Xiuyan Wang, Claudia Diamonte, Jae H. Park, Brigitte Sénéchal, Terence J. Purdon, Yvette Bernal and Yongzeng Wang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.